Pharmaceutical compound based on metformin for weight control.

Pharmaceutical compound for weight control.

The patent is pending No. PCT/IB2021/053179 / US63116794 in Europe and the United States respectively.

the technology describes a pharmaceutical complex for weight control, obtained from metformin, transition metals and elements such as nickel, copper and bismuth, obtaining a drug with therapeutic potential for the treatment of patients with obesity or overweight.

Health

health. pharmaceutical industry / weight treatment.

weight reduction, contains organic active ingredients, reduces appetite and fat absorption.

The product contains organic active ingredients and through different mechanisms such as appetite reduction and reduction of fat absorption can achieve weight loss of at least 5 kg in one month.
It decreases treatment time, the dose required is low and this dose of the active ingredient can be obtained without a prescription.
Potential treatments for other diseases have been found with this complex such as: blood glucose regulation, anti-aging, potential malaria treatment and potential cancer treatment.

Universidad Santiago de Cali.

TRL4